Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate

Molecular and Cellular Endocrinology

Volumn 160, Issue 1-2, 2000, Pages 61-66

  Singh, A ^a   Purohit, A ^a   Hejaz, H A M ^b   Potter, B V L ^b   Reed, M J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

Author keywords

2 Methoxyestrogens; 2 Methoxyestrone 3 O sulfamate; Breast cancer; Glucose uptake

Indexed keywords

2 HYDROXYESTRADIOL; 2 METHOXYESTRONE; 2 METHOXYESTRONE 3 O SULFAMATE; DEOXYGLUCOSE; ESTRADIOL 3 METHYL ETHER; ESTRONE GLUCURONIDE; ESTRONE SULFATE; INSULIN; PACLITAXEL; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; MICROTUBULE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; BREAST NEOPLASMS; DEOXYGLUCOSE; ESTRADIOL; ESTRONE; FEMALE; HUMANS; HYDROXYESTRONES; INSULIN; KINETICS; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 0034712269     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00256-7     Document Type: Article

References (28)

1. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S.-I., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
2. Attalla H., Mäkelä T.P., Adlercreutz H., Andersson L.C. 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem. Biophys. Res. Commun. 228:1996;467-473.
3. Birnbaum M.J., Haspel H.C., Rosen O.M. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science. 235:1987;1495-1498.
4. Brown R.S., Wahl R.L. Overexpression of GLUT-1 glucose transporter in human breast cancer. Cancer. 72:1993;2979-2985.
5. D'Amato R.J., Lin C.M., Flynn E., Folkman J., Hamel E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl. Acad. Sci. USA. 91:1994;3964-3968.
6. Elger W., Schwarz S., Hedden A., Reddersen G., Schneider B. Sulfamates of various estrogens as prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. J. Steroid Biochem. Molec. Biol. 55:1995;395-403.
7. Elger W., Palme H.-J., Schwarz S. Novel oestrogen sulfamates: a new approach to oral hormone therapy. Exp. Opin. Invest. Drugs. 7:1998;575-589.
8. Flier J.S., Mueckler M.M., Usher P., Lodish H.F. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science. 235:1987;1492-1495.
9. Fotsis T., Zhang Y., Pepper M.S., Adlercreutz H., Montesano R., Nawroth P.P., Schweigerer L. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature. 368:1994;237-239.
10. Glass-Marmor L., Beitner R. Taxol (paclitaxel) induces a detachment of phosphofructokinase from cytoskeleton of melanoma cells and decreases levels of glucose 1,6-bisphosphate, fructose 1,6-bisphosphate and ATP. Eur. J. Pharmacol. 370:1999;195-199.
11. Gould G.W., Holman G.D. The glucose transporter family: structure, function and tissue-specific expression. Biochem. J. 295:1993;329-341.
12. Hamilton-Wessler, M., Ader, M., Getty, L., Dea, M., Hamm-Alvarez, S., Bergman, R.N., 1996. Microtubule-disrupting agent taxol reduces insulin-stimulated glucose uptake in vivo. Diabetes 45 (Suppl. 2), Abstr. 615.
13. Howarth N.M., Purohit A., Reed M.J., Potter B.V.L. Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. J. Med. Chem. 37:1994;219-221.
14. Klauber N., Parangi S., Flynn E., Hamel E., D'Amato R.J. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res. 57:1997;81-86.
15. Mazurek S., Michel A., Eigenbrodt E. Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. J. Biol. Chem. 272:1997;4941-4952.
16. Purohit A., Williams G.J., Howarth N.M., Potter B.V.L., Reed M.J. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Biochemistry. 34:1995;11508-11514.
17. Purohit A., Vernon K.A., Wagenaar-Humelinck A.E., Woo L.W.L., Hejaz H.A.M., Potter B.V.L., Reed M.J. The development of A-ring modified analogues of oestrone-3-O-sulphamate as steroid sulphatase inhibitors with reduced oestrogenicity. J. Steroid Biochem. Molec. Biol. 64:1998;269-275.
18. Purohit, A., Hejaz, H.A.M., Walden, L., MacCarthy-Morrogh, L., Packham, G., Potter, B.V.L., Reed, M.J., 1999.The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours. Int. J. Cancer 85, 584-589.
19. Seegers J.C., Aveling M.-L., Van Aswegen C.H., Cross M., Koch F., Joubert W.S. The cytotoxic effects of estradiol-17β, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J. Steroid Biochem. 32:1989;797-809.
20. Seegers J.C., Lottering M.L., Grobler C.J., Van Papendorp D.H., Habbersett R.C., Shou Y., Lehnert B.E. The mammalian metabolite, 2-methoxyestradiol affects p53 levels and apoptosis induction in transformed cells but not in normal cells. J. Steroid Biochem. Molec. Biol. 62:1997;253-267.
21. Shim H., Chun Y.-S., Lewis B.C., Dang C.V. A unique glucose-dependent apoptotic pathway induced by c-myc. Proc. Natl. Acad. Sci. USA. 95:1998;1511-1516.
22. Tsakiridis T., Vranic M., Klip A. Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J. Biol. Chem. 269:1994;29934-29942.
23. Vera J.C., Reyes A.M., Carcamo J.G., Velasquez F.V., Rivas C.I., Zhang R.H., Strobel P., Iribarren R., Scher H.I., Slebe J.C., Golde D.W. Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, GLUT1. J. Biol. Chem. 271:1996;8719-8724.
24. Warburg O. On the origin of cancer cells. Science. 125:1956;309-314.
25. Woo L.W.L., Purohit A., Reed M.J., Potter B.V.L. Active site directed inhibition of estrone sulfatase by non-steroidal coumarin sulfamates. J. Med. Chem. 39:1996;1349-1351.
26. Younes M., Lechago L.V., Somoano J.R., Mosharaf M., Lechago J. Wide expression of the human erythrocyte glucose transporter GLUT-1 in human cancers. Cancer Res. 56:1996;1164-1167.
27. Zamora-Leon P., Golde D.W., Concha I.I., Rivas C.I., Delgado-Lopez F., Baselga J., Nualart F., Vera J.C. Expression of the fructose transporter GLUT-5 in human breast cancer. Proc. Natl. Acad. Sci. 93:1996;1847-1852.
28. Zhu B.T., Conney A.H. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis. Cancer Res. 58:1998;2269-2277.